Issue 100, 2021

A novel near-infrared theranostic probe for accurate cancer chemotherapy in vivo by a dual activation strategy

Abstract

A novel theranostic probe called CX-B-DF is constructed for precise chemotherapy guided by near-infrared (NIR) fluorescence imaging. Moreover, the theranostic probe shows high cytotoxicity to cancer cells under dual activation (H2O2 and TP), which causes the accuracy of drug release to be improved and the toxic side effects to be reduced.

Graphical abstract: A novel near-infrared theranostic probe for accurate cancer chemotherapy in vivo by a dual activation strategy

Supplementary files

Article information

Article type
Communication
Submitted
18 Oct 2021
Accepted
24 Nov 2021
First published
03 Dec 2021

Chem. Commun., 2021,57, 13768-13771

A novel near-infrared theranostic probe for accurate cancer chemotherapy in vivo by a dual activation strategy

W. Wang, W. Jiang, G. Mao, Z. Tan, M. Tan and C. Li, Chem. Commun., 2021, 57, 13768 DOI: 10.1039/D1CC05864A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements